F901318 (olorofim)

Showing 10 posts of 15 posts found.

Title

Date

F901318 Single Ascending Dose Study in Healthy Male Volunteers

13 May 2014
F901318 Multiple Ascending Dose Study

15 January 2015
Single Ascending Oral Dose Study of F901318

16 March 2015
F2G Ltd Announces the Acceptance of F901318 to Participate in the EMA’s Adaptive Pathways Pilot Programme.

3 December 2015
F901318 Single Ascending Dose Study in Healthy Male Volunteers

13 May 2014
F901318 Multiple Ascending Dose Study

15 January 2015
Single Ascending Oral Dose Study of F901318

16 March 2015
Drug discovery

15 September 2015
Activity of E901318

19 September 2015
Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe

4 April 2016

Back to New Antifungals

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
27 June 2021 New form of itraconazole available – improved absorption
29 January 2021 3rd Essential Diagnostics’ List Launch